GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: The chemical structure for envudeucitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential.
|
|
Bioactivity Comments |
We have been unable fo find any open source information in support of envudeucitinib's proposed mechanism of action or primary molecular target(s). |